The judge overseeing Elmiron federal lawsuits filed over retinal damage claims has put forward a schedule to begin preparing cases for the first early trial dates.
A federal judge has approved plaintiff and defendant fact sheets designed to help streamline federal Elmiron litigation over claims of retinal damage and vision loss.
Elmiron litigation moves forward with plans for remote depositions, a Science Day, and other plans which would lead to the first bellwether trial in January 2023.
A new study finds that 20% of long-term Elmiron users are likely to develop retinal damage due to the side effects of the bladder pain drug.
A federal judge has allowed direct filing of future Elmiron lawsuits over claims of vision loss.
About 200 Elmiron vision lawsuits have been filed to date, and that number is expected to grow as the federal litigation moves forward.
A new study warns that long-term Elmiron use could cause maculopathy and vision loss in up to 20% of long-term users.
An Elmiron lawsuit filed by a Kentucky woman indicates she suffered irreversible vision loss due to the bladder pain drug's side effects.
A new study finds Elmiron-related maculopathy, which can cause retinal changes and vision loss, can be identified through imaging due to its specific nature.
An Elmiron lawsuit by a woman who suffered numerous vision problems says the manufacturers should have provided warnings about maculopathy risks.